Sei Investments CO Vericel Corp Transaction History

Sei Investments CO

  • $75 Billion
  • Q1 2025

A detailed history of Sei Investments CO transactions in Vericel Corp stock. As of the latest transaction made, Sei Investments CO holds 57,350 shares of VCEL stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,350
Previous 62,024 7.54%
Holding current value
$2.37 Million
Previous $2.77 Million 7.55%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$44.5 - $61.8 $207,993 - $288,853
-4,674 Reduced 7.54%
57,350 $2.56 Million
Q1 2025

May 13, 2025
BUY
$44.5 - $61.8 $92,515 - $128,482
2,079 Added 3.47%
62,024 $2.77 Million
Q4 2024

Feb 11, 2025
SELL
$40.05 - $59.11 $213,065 - $314,465
-5,320 Reduced 8.15%
59,945 $3.29 Million
Q3 2024

Nov 12, 2024
BUY
$42.25 - $53.56 $132,073 - $167,428
3,126 Added 5.03%
65,265 $2.76 Million
Q2 2024

Aug 13, 2024
BUY
$41.71 - $52.9 $533,846 - $677,067
12,799 Added 25.94%
62,139 $2.85 Million
Q1 2024

May 07, 2024
BUY
$32.52 - $52.33 $530,466 - $853,606
16,312 Added 49.39%
49,340 $2.57 Million
Q4 2023

Feb 14, 2024
SELL
$30.85 - $37.09 $3.31 Million - $3.98 Million
-107,256 Reduced 76.46%
33,028 $1.18 Million
Q3 2023

Nov 14, 2023
BUY
$31.69 - $39.25 $1.21 Million - $1.5 Million
38,246 Added 37.48%
140,284 $4.7 Million
Q2 2023

Aug 11, 2023
BUY
$29.0 - $38.37 $1.89 Million - $2.5 Million
65,040 Added 175.79%
102,038 $3.83 Million
Q1 2023

May 12, 2023
BUY
$23.85 - $31.34 $882,402 - $1.16 Million
36,998 New
36,998 $1.08 Million
Q3 2022

Nov 14, 2022
SELL
$22.62 - $32.54 $2.61 Million - $3.75 Million
-115,311 Reduced 52.09%
106,037 $2.46 Million
Q2 2022

Aug 15, 2022
BUY
$22.88 - $39.45 $4.79 Million - $8.26 Million
209,301 Added 1737.37%
221,348 $5.57 Million
Q1 2022

May 13, 2022
BUY
$31.69 - $43.29 $193,213 - $263,939
6,097 Added 102.47%
12,047 $460,000
Q4 2021

Feb 14, 2022
SELL
$35.2 - $52.6 $440,070 - $657,605
-12,502 Reduced 67.75%
5,950 $234,000
Q3 2021

Nov 12, 2021
SELL
$46.35 - $59.75 $1.1 Million - $1.42 Million
-23,822 Reduced 56.35%
18,452 $900,000
Q2 2021

Aug 06, 2021
BUY
$47.2 - $67.81 $153,541 - $220,585
3,253 Added 8.34%
42,274 $2.22 Million
Q1 2021

May 12, 2021
BUY
$30.93 - $59.48 $212,829 - $409,281
6,881 Added 21.41%
39,021 $1.81 Million
Q4 2020

Feb 08, 2021
BUY
$18.53 - $31.5 $392,280 - $666,855
21,170 Added 192.98%
32,140 $993,000
Q3 2020

Dec 04, 2020
SELL
$14.68 - $19.12 $4,433 - $5,774
-302 Reduced 2.68%
10,970 $203,000
Q3 2020

Nov 06, 2020
BUY
$14.68 - $19.12 $234 - $305
16 Added 0.14%
11,272 $209,000
Q2 2020

Aug 17, 2020
BUY
$8.5 - $15.82 $5,644 - $10,504
664 Added 6.27%
11,256 $158,000
Q2 2020

Aug 11, 2020
SELL
$8.5 - $15.82 $39,312 - $73,167
-4,625 Reduced 30.39%
10,592 $180,000
Q1 2020

May 14, 2020
BUY
$7.25 - $19.22 $36,989 - $98,060
5,102 Added 50.44%
15,217 $140,000
Q4 2019

Feb 06, 2020
BUY
$13.77 - $19.2 $139,283 - $194,208
10,115 New
10,115 $176,000
Q3 2019

Nov 12, 2019
SELL
$14.93 - $19.83 $198,300 - $263,382
-13,282 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$15.01 - $18.89 $388,338 - $488,722
-25,872 Reduced 66.08%
13,282 $251,000
Q1 2019

May 15, 2019
SELL
$16.23 - $20.29 $1.44 Million - $1.8 Million
-88,877 Reduced 69.42%
39,154 $685,000
Q4 2018

Feb 13, 2019
BUY
$10.77 - $18.44 $505,123 - $864,854
46,901 Added 57.81%
128,031 $1.96 Million
Q3 2018

Nov 08, 2018
BUY
$9.1 - $14.8 $736,918 - $1.2 Million
80,980 Added 53986.67%
81,130 $1.15 Million
Q2 2018

Aug 03, 2018
BUY
$9.6 - $14.6 $1,440 - $2,190
150 New
150 $1,000
Q4 2017

Feb 08, 2018
SELL
$3.65 - $5.98 $102 - $167
-28 Closed
0 $0
Q3 2017

Nov 06, 2017
BUY
$3.0 - $6.0 $84 - $168
28
28 $0

Others Institutions Holding VCEL

# of Institutions
291
Shares Held
52.1M
Call Options Held
36.7K
Put Options Held
6.4K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.95B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email